Sucampo Provides Update to 2015 and Confirms 2016 Financial Guidance Post Closing of R-Tech Ueno Acquisition
07 janv. 2016 07h00 HE
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today provided additional detail regarding its...
Sucampo to Return All Licenses for Unoprostone Isopropyl to R-Tech Ueno
09 mars 2015 02h40 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., March 9, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced it will immediately return all licenses for...
Sucampo Announces Resolution of Par Pharmaceutical's ANDA for RESCULA(R)
11 févr. 2015 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Feb. 11, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo and R-Tech Ueno, Ltd. (RTU),...
Sucampo Announces New Exclusive Global Manufacturing and Supply Agreement for Lubiprostone
21 août 2014 16h30 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Aug. 21, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that its subsidiary, Sucampo AG, has signed...